Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Delayed
Japan Exchange
22:30:00 2026-10-18 EDT
|
5-day change | 1st Jan Change | ||
| 6,249.00 JPY | +0.42% |
|
+4.80% | +29.25% |
| 10-15 | Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading | MT |
| 10-15 | Takeda Pharmaceutical Launches Orzeyful in Japan and China | MT |
| Market Cap | 9,937B 62.94B 55.94B 51.85B 47.18B 89.03B 5,973B 90.45B 623B 244B 3,117B 236B 231B | P/E 2027 * |
49.3x | P/E 2028 * | 31.3x |
|---|---|---|---|---|---|
| Enterprise Value | 13,843B 87.68B 77.94B 72.24B 65.73B 124B 8,322B 126B 868B 340B 4,343B 329B 322B | EV / Sales 2027 * |
2.94x | EV / Sales 2028 * | 2.84x |
| Free-Float |
99.18% | Yield 2027 * |
3.28% | Yield 2028 * | 3.35% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
OTC Markets
| TKPHF | Delayed | |
|
Deutsche Boerse AG
| TKD | Delayed | |
|
Börse Stuttgart
| TKD | Delayed | |
|
Tradegate
| TKD | Real-time | |
|
Boerse Muenchen
| TKD | Real-time | |
|
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.42% | ||
| 1 week | +4.80% | ||
| Current month | +8.11% | ||
| 1 month | +6.19% | ||
| 3 months | +12.49% | ||
| 6 months | +12.09% | ||
| Current year | +29.25% |
| 1 week | 5,824 |  | 6,315 |
| 1 month | 5,606 | | 6,315 |
| Current year | 4,710 | | 6,315 |
| 1 year | 4,102 | | 6,315 |
| 3 years | 3,852 | | 6,315 |
| 5 years | 2,993 | | 6,315 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2024-12-31 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 48 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 61 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/14/26 | Sell | Executive/Senior Manager | -34,535 | 0.0022% | ||
| 9/2/26 | Sell | Chief Technology Officer | -116,191 | 0.0073% | ||
| 8/19/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | +4.80% | +48.01% | +43.23% | 62.94B | |
| +0.43% | +6.59% | +56.57% | +107.01% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +67.33% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.20% | 504B | |
| -0.13% | +5.98% | +33.66% | +52.01% | 367B | |
| +0.52% | +0.24% | +72.13% | +43.10% | 360B | |
| -0.95% | +4.70% | +19.65% | +43.09% | 288B | |
| -1.98% | +3.73% | -0.89% | +17.28% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.51% | 234B | |
| -0.75% | +3.32% | +27.18% | +96.05% | 194B | |
| Average | -0.12% | +3.63% | +35.76% | +61.28% | 400.38B | |
| Weighted average by Cap. | +0.14% | +3.57% | +39.47% | +73.04% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,704B 29.79B 26.48B 24.55B 22.33B 42.14B 2,828B 42.82B 295B 116B 1,476B 112B 109B | 4,796B 30.37B 27B 25.03B 22.77B 42.97B 2,883B 43.65B 301B 118B 1,504B 114B 112B |
| Net income | 197B 1.25B 1.11B 1.03B 933M 1.76B 118B 1.79B 12.33B 4.83B 61.66B 4.67B 4.57B | 323B 2.05B 1.82B 1.69B 1.53B 2.9B 194B 2.94B 20.27B 7.95B 101B 7.68B 7.52B |
| Net Debt | 3,907B 24.74B 21.99B 20.39B 18.55B 35B 2,348B 35.56B 245B 96.08B 1,225B 92.86B 90.89B | 3,704B 23.46B 20.85B 19.33B 17.59B 33.18B 2,227B 33.72B 232B 91.09B 1,162B 88.05B 86.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-18 | JP¥6,249.00 | +0.42% | 1,574,200 |
| 26-10-16 | JP¥6,223.00 | +0.65% | 4,816,000 |
| 26-10-15 | JP¥6,183.00 | +4.99% | 9,741,500 |
| 26-10-14 | JP¥5,889.00 | -1.24% | 3,604,400 |
| 26-10-13 | JP¥5,963.00 | +2.05% | 4,001,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
